Edge Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Edge Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-27,756	Closed	-$572K	–	278
2016 Q1	$572K	Sell	27,756 -91,018	-77%	-$1.79M	0.01%	263
2015 Q4	$2.44M	Sell	118,774 -36,024	-23%	-$691K	0.02%	263
2015 Q3	$2.65M	Buy	+154,798	New	+$2.83M	0.03%	256
2013 Q4	–	Sell	-107,707	Closed	-$2.31M	–	309
2013 Q3	$2.31M	Hold	107,707	–	–	0.01%	280
2013 Q2	$2.31M	Buy	+107,707	New	+$2.32M	0.03%	270

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Edge Asset Management's VIVO Position: Q2 2016 in Review

Edge Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2016, closing a stake of 27,756 shares — an estimated $572K sold.

Edge Asset Management first reported a position in VIVO in Q2 2013 and held it in 5 quarters. The position peaked at $2.65M in Q3 2015. 180 funds tracked by Wall St. Rank hold VIVO as of Q2 2016.

Edge Asset Management reported no remaining Meridian Bioscience Inc position as of Q2 2016 after selling out during the quarter.
Edge Asset Management sold 27,756 Meridian Bioscience Inc shares in Q2 2016, an estimated $572K.
Edge Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 5 quarters.
Edge Asset Management's Meridian Bioscience Inc position peaked at $2.65M in Q3 2015.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2016.

Based on Edge Asset Management's 13F filing for Q2 2016, filed 9 Aug 2016.